SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Clinical Cancer Research Publishes OncoMed Pharmaceuticals, Inc. Data Demonstrating Anti-Cancer Activity for Anti-DLL4 (Demcizumab) in Pancreatic Cancer